Similarly, p21Cip1 has been shown to be increased in prostate cancer and holds potential merit as a prognostic indicator (Matsushima et al, 1998; Sarkar et al, 1999; Omar et al, 2001; Rigaud et al, 2004). Here, CDKN1A is linked to prostate carcinoma.